ArticleProceedings of the National Academy of Sciences of the United States of America2019

The IκB-protein BCL-3 controls Toll-like receptor-induced MAPK activity by promoting TPL-2 degradation in the nucleus.

Patricia E Collins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.